Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000808200 | SCV000948296 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2Y | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the TOR1AIP1 gene. It does not directly change the encoded amino acid sequence of the TOR1AIP1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs139072070, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TOR1AIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 652615). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001655601 | SCV001871186 | uncertain significance | not provided | 2024-03-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 33820833) |
Genome- |
RCV000808200 | SCV004172378 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2Y | 2023-04-11 | criteria provided, single submitter | clinical testing |